Technical Analysis for GUD - Knight Therapeutics Inc.

Grade Last Price % Change Price Change
D 5.21 -2.07% -0.110
GUD closed down 2.07 percent on Monday, May 10, 2021, on 1.27 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical GUD trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
20 DMA Resistance Bearish -2.07%
50 DMA Support Bullish -2.07%
Spinning Top Other -2.07%
Fell Below 20 DMA Bearish -1.33%
MACD Bearish Signal Line Cross Bearish -1.33%
20 DMA Support Bullish -3.34%
20 DMA Support Bullish -3.16%
50 DMA Support Bullish -3.16%
Older End-of-Day Signals for GUD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1 ATR 7 days ago
Fell Below Previous Day's Low 7 days ago
Down 2% 7 days ago
Down 1% 7 days ago
Fell Below 50 DMA 7 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Knight Therapeutics Inc. Description

Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally. Its prescription pharmaceuticals and medical devices in various stages of development include Impavido, AzaSite, ATryn, Photofrin, ILUVIEN, TULSA-PRO, PROBUPHINE, Advaxis Family of Products, Ember Family of Products, NeurAxon Family of Products, Antibe Family of Products, Blood Factor Products and VEWS Vascular Early Warning System. In addition, the Company also has a portfolio of branded consumer health products, including Neuragen, Flat Tummy Tea, FOCUSFactor, FLEXISEQ, SEQuaderma, HandMD, UrgentRx, Laboratoire Dr. Renaud, Premiology and Pro-Derm.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Marketing Pharma Pharmaceutical Labor Science Life Sciences Pharmaceuticals Pharmaceutical Products Medical Devices Pharmaceutical Industry Pharmaceutical Sciences Pharmaceutical Industry In China Consumer Health Products

Is GUD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.81
52 Week Low 4.88
Average Volume 400,230
200-Day Moving Average 5.638
50-Day Moving Average 5.277
20-Day Moving Average 5.331
10-Day Moving Average 5.370
Average True Range 0.132
ADX 16.43
+DI 19.332
-DI 21.809
Chandelier Exit (Long, 3 ATRs ) 5.343
Chandelier Exit (Short, 3 ATRs ) 5.537
Upper Bollinger Band 5.497
Lower Bollinger Band 5.164
Percent B (%b) 0.14
BandWidth 6.255
MACD Line 0.001
MACD Signal Line 0.017
MACD Histogram -0.0157
Fundamentals Value
Market Cap 679.1 Million
Num Shares 130 Million
EPS 0.20
Price-to-Earnings (P/E) Ratio 26.18
Price-to-Sales 4.06
Price-to-Book 0.82
PEG Ratio 2856.67
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.420
Resistance 3 (R3) 5.440 5.390 5.385
Resistance 2 (R2) 5.390 5.337 5.380 5.373
Resistance 1 (R1) 5.300 5.303 5.275 5.280 5.362
Pivot Point 5.250 5.250 5.238 5.240 5.250
Support 1 (S1) 5.160 5.197 5.135 5.140 5.058
Support 2 (S2) 5.110 5.163 5.100 5.047
Support 3 (S3) 5.020 5.110 5.035
Support 4 (S4) 5.000